Addressing the challenges of adherence

Journal of Acquired Immune Deficiency Syndromes

Volumn 29, Issue SUPPL. 1, 2002, Pages

  Bartlett, John A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adherence; AIDS; Antiretroviral therapy; Compliance; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

COMORBIDITY; DEPRESSION; DRUG INDUCED DISEASE; HEALTH CARE DELIVERY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESTYLE; MEMORY; MOTIVATION; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; PILL; PRIORITY JOURNAL; REVIEW; SELF REPORT; TEAMWORK; TREATMENT OUTCOME; TREATMENT PLANNING; VIRUS LOAD;

EID: 0036471409     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200202011-00002     Document Type: Review

References (28)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
3. Adherence to antiretroviral regimens in HIV-infected patients: Results of a survey among physicians and patients
4. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments
5. Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease
6. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
7. Partial medication compliance: The enigma in poor medical outcomes
8. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
9. Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy
10. Nonadherence to triple combination therapy is predictive of AIDS progression and death in HIV-positive men and women
11. Attaining higher goals in HIV treatment: The central importance of adherence
12. Adherence to highly active antiretroviral therapy
13. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy
14. Patient characteristics and attitudes associated with antiretroviral (AR) adherence
15. Self-reported antiretroviral adherence correlates with HIV viral load and declines over time
16. A comparison study of multiple measures of adherence to HIV protease inhibitors
17. Predictors of adherence with triple combination antiretroviral therapy
18. Adherence to protease inhibitor (PI) therapy in clinical practice: Usefulness of demographics, attitudes and knowledge as predictors
19. Adherence to combination antiretroviral therapies in HIV patients of low health literacy
20. Adherence and viral load in HIV-infected drug users: Comparison of self-report and medication event monitors (MEMS)
21. Which patients get an "A" for adherence?
22. Adherence to highly active antiretroviral therapy in substance abusers with HIV/AIDS
23. Overview of the effectiveness of triple-combination therapy in antiretroviral-naive HIV-1-infected adults
24. Management of the adverse effects of antiretroviral therapy and medication adherence
25. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial
26. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults
27. Peer support for HAART adherence in Harlem